Coherus and Junshi Biosciences Announce Positive Results from Phase 3 Esophageal Cancer Study of…
- Toripalimab plus chemotherapy demonstrates improvement in co-primary endpoints of PFS and OS in patients with advanced ESCC - - PFS and OS benefits were observed across all PD-L1 expression subgroups, including in patients with low…